Clinical Trial Update: Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating serplulimab combined with CAPEOX and celecoxib as neoadjuvant therapy for locally advanced rectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Celecoxib (Celecoxib)
• OXALIPLATIN (Oxaliplatin)
• Serplulimab (serplulimab)

Snippet

Sponsor: Zhejiang University | Conditions: pMMR, MSS | Phase 2 | Status: RECRUITING